Biogen Inc. Depositary Receipt (BIIB34)
Market Closed
12 Jun, 19:55
B3 B3 Primary R$
162. 08
0
0%
R$
144.29B Market Cap
24.69 P/E Ratio
- Div Yield
434 Volume
14.99 Eps
R$ 162.08
Previous Close Want to track BIIB34 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Biogen Inc. Depositary Receipt (BIIB34) Statistics
Valuation metrics
Market Cap 144.29B
Enterprise value 132.94B
Trailing P/E (ttm) 20.91
Forward P/E -
PEG ratio 0.66
Price/Sales (ttm) 14.52
Price/Book (mrq) 1.54
Enterprise Value/Revenue 2.64
Enterprise Value/EBITDA 7.46
Overview
Shares outstanding 147.6M
Float 147.15M
Shares short -
% Held by insiders -
% Held by institutions 0%
Average volume (10 days) 16
Average volume (90 days) 23
Price summary
52-Week low 113.64
52-Week high 172.26
Beta 0.2
50-Day moving average 157.82
200-Day moving average 148.47
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.14%
Operating margin 0.23%
Operational effectiveness
Return on assets 0.06%
Return on equity 0.08%
Income Statement
Revenue (ttm) 50.36B
Revenue per share (ttm) 11.31
Quarterly revenue growth (yoy) 0.02%
Gross profit (ttm) 39.65B
EBITDA 3.27B
Net income to common (ttm) 6.95B
Diluted EPS (ttm) 7.76
Quarterly earnings growth (yoy) 0.33%
Balance Sheet
Total cash (mrq) 21.7B
Total cash per share (mrq) 29.01
Total debt (mrq) 33.26B
Total Debt/Equity (mrq) 35.18
Current ratio (mrq) 3.06%
Book value per share (mrq) 105.67
Cash Flow
Cash flow statement 13.13B
Levered free cash flow (LFCF) 9.71B
